36 employees
Traversa Therapeutics develops RNAi delivery technologies for therapeutic companies to target a variety of infectious human diseases.
2012
$2M
from 1 investors over 1 rounds
Traversa Therapeutics, Inc raised $2M on February 4, 2008
Investors: -